Fred Holubow

CIK 905478 · last filed 2023-06-15

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$1.19M

Companies

Total Filings

Lifetime Open-Market Net

-$159.6K

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

MEND price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest

OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
TGEN	Director	—	$1.98	—	$0	3	2023-06-15
ANI PHARMACEUTICALS INC (FOLD) Delisted	Director	14,811	$14.49	$214.6K	$0	2	2018-03-22
ANIP	Director	16,533	$71.98	$1.19M	$0	4	2016-04-11
ANI PHARMACEUTICALS INC (BPAX) Delisted	Director	10,210	—	—	$0	6	2013-07-16
MICRUS ENDOVASCULAR CORP (MEND) Delisted	Director	0	—	—	-$108.7K	5	2010-09-28
ANI PHARMACEUTICALS INC (BPA) Delisted	Director	62,759	—	—	-$50.9K	1	2007-05-08

Recent Filings · Page 3 of 3

21 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2007-05-08	ANI PHARMACEUTICALS INC (BPA) Delisted	Mixed	−8,700	-$50.9K	EDGAR

Showing 21–21 of 21

Prev Page 3 of 3

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.